In the past week, Oracle announced a series of new AI- and cloud-driven deals and products, including US$88 million in Oracle Cloud Infrastructure services for the U.S. Department of the Air Force, expanded cloud use by the Centers for Medicare & Medicaid Services and the City of Atlanta, and broader deployment of Oracle Health’s Clinical AI Agent in the UK.
These moves highlight how Oracle is pushing AI agents and sector-specific cloud platforms deeper into government, healthcare, and municipal workflows, even as investors weigh this expansion against concerns over large AI infrastructure spending and related legal challenges.
We’ll now examine how this wave of public-sector and AI agent wins interacts with Oracle’s heavy AI infrastructure commitments and overall investment narrative.
The future of work is here. Discover the 34 top robotics and automation stocks leading the charge in AI-driven automation and industrial transformation.
To own Oracle today, you have to believe its massive AI and cloud buildout will translate a swelling contract backlog into durable, profitable growth, despite heavy CapEx and dependence on a handful of AI hyperscale customers. This week’s government and healthcare wins support the demand side of that story, but they do little to blunt the immediate risk around funding and executing Oracle’s very large AI infrastructure program and the legal scrutiny it has drawn.
The US$88 million U.S. Department of the Air Force Cloud One task order stands out here, because it directly reinforces Oracle Cloud Infrastructure and AI Database 26ai as part of mission-critical, multi‑year workloads. For investors focused on near term catalysts, it is another proof point that Oracle is still landing large, regulated customers on OCI even as questions around OpenAI concentration, higher CapEx, and free cash flow remain unresolved.
Yet behind these wins, investors should also weigh how much of Oracle’s future hinges on a single, very large OpenAI contract and the funding, timing, and execution risks around data centers that are only expected to be fully online by…
Read the full narrative on Oracle (it’s free!)
Oracle’s narrative projects $99.5 billion revenue and $25.3 billion earnings by 2028. This requires 20.1% yearly revenue growth and a $12.9 billion earnings increase from $12.4 billion today.
Uncover how Oracle’s forecasts yield a $291.08 fair value, a 86% upside to its current price.
ORCL 1-Year Stock Price Chart
Some of the lowest estimate analysts already assumed a slower path with Oracle’s revenue reaching about US$90.8 billion and earnings of roughly US$24.3 billion by 2028, and they worry that a shift toward more open, interoperable AI platforms could accelerate customer churn. Compared with the consensus, these skeptics represent a much more cautious view, and the latest AI and public sector deals may eventually push them to revisit just how fragile or resilient Oracle’s long term cloud story really is.
Explore 28 other fair value estimates on Oracle – why the stock might be worth over 2x more than the current price!
Don’t just follow the ticker – dig into the data and build a conviction that’s truly your own.
Markets shift fast. These stocks won’t stay hidden for long. Get the list while it matters:
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Companies discussed in this article include ORCL.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com